Aims The aim of the present paper was to provide an up‐to‐date view on epidemiology and
risk factors of heart failure (HF) development after myocardial infarction. Methods and results …

Objectives: To characterize the presentation and outcome of patients with heart failure (HF)
after myocardial infarction (MI) according to left ventricular ejection fraction (LVEF) and test …

Myocardial infarction (MI) remains the most common cause of heart failure (HF) worldwide.
For almost 50 years HF has been recognised as a determinant of adverse prognosis after …

Heart failure (HF) is a major public health issue, with a prevalence of over 5.8 million in the
USA, and over 23 million worldwide, and rising. The lifetime risk of developing HF is one in …

Background—Contemporary data are lacking on the prognostic importance of heart failure
(HF) after myocardial infarction (MI). We evaluated the prognostic impact of HF post MI …

Despite remarkable therapeutic advances in the management of patients with heart failure
(HF), the mortality due to this syndrome remains high [1]. Identifying free-living individuals …

HF treatment have resulted from clinical trials, epidemiological investigations complement
clinical trials by enhancing our ability to identify individuals at risk and, in turn, facilitate the …

Heart failure is a frequent complication of myocardial infarction. Several factors, such as
recurrent myocardial ischemia, infarct size, ventricular remodeling, stunned myocardium …

Background Coronary heart disease (CHD) represents often the underlying conditions for
the development of heart failure (HF). We aimed at exploring the burden and timing of HF …

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of>
37.7 million individuals globally. HF is a shared chronic phase of cardiac functional …